At Karmagenes, we do behavioral genetic and psychological analysis to improve people’s personal and professional life. Karmagenes SA is a Swiss-based startup and its scientific team has developed proprietary algorithms that a) provide an unbiased view of genetic potential through DNA-based personality test, b) assess current personality through KG5+ psychological tool and c) offer custom advice through in-house psychologist regarding career orientation, partnership and wellbeing.
Since more than 450mio people have a bad mental being affecting their capacity ‘’to work and to love’’, our next step is to apply our technology to a life coaching app combining psychological and genetic data analysis coupled with artificial intelligence.
At your fingertip, you will have access to our existing network of coaches and specialists who can help you improve your overall wellbeing by understanding the real you.
Torreya Partners is a leading corporate finance advisory boutique serving companies in the life sciences industry.
Founded by Tim Opler and Mark Simon, Torreya has grown to have more than 50 professionals and a global presence in life sciences advisory. We have successfully completed more than 150 assignments since we started in August 2007.
Torreya has its primary offices in London, New York and Mumbai.
Our work has taken place in pharmaceuticals, biotechnology, medical technology, diagnostics, nutritionals, pharma services and closely related sectors. Our partners are senior industry bankers and executives, with deep experience, knowledge, and networks.
We are a partner of choice for companies seeking discreet, unconflicted and knowledgeable advice on M&A, corporate finance, licensing and asset sale transactions. In some cases, Torreya Partners acts as a pure advisor on a retained basis to its clients.
Stephanie Léouzon is Partner and Head of Europe for Torreya Partners, a life sciences boutique advisory firm which she joined in 2012. Previously she worked in healthcare investment banking in the US and Europe from 1989 to 2010, most recently at Credit Suisse in London as a Managing Director and Senior Advisor.
She has advised life sciences clients on more than 25 strategic transactions, valued at over
$65 billion, and has been involved in over 45 financing transactions to provide over $10 billion to healthcare clients.
Stephanie earned an MBA degree from the Darden Graduate School of Business at the University of Virginia in 1989 and a BA degree, cum laude, from Mount Holyoke College in 1985.
Responsive Web Design powered by 